These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14192603)

  • 1. [THE VALUE OF FRACTIONAL CLEARANCE OF BSP IN THE DIAGNOSIS OF CHRONIC HEPATOPATHIES].
    NICOLAESCU T; FELBERG B; RUSOVICI L
    Med Interna (Bucur); 1964 Aug; 16():959-67. PubMed ID: 14192603
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.
    SCHOENFIELD LJ; FOULK WT; BUTT HR
    J Clin Invest; 1964 Jul; 43(7):1409-18. PubMed ID: 14192521
    [No Abstract]   [Full Text] [Related]  

  • 3. [INDEXES OF BSP CLEARANCE IN CHRONIC HEPATITIS AND CIRRHOSIS].
    PIEPTEA R; MIHALACHE N; PAVEL I
    Med Interna (Bucur); 1964 Nov; 16():1303-12. PubMed ID: 14245936
    [No Abstract]   [Full Text] [Related]  

  • 4. [The BSP purification tests].
    Chevrel B
    Presse Med (1893); 1969 Apr; 77(18):682. PubMed ID: 5790092
    [No Abstract]   [Full Text] [Related]  

  • 5. [COMPARISON BETWEEN ELIMINATION OF BROMOSULFONPHTHALEIN AND ANATOMIC-HISTOLOGIC ALTERATIONS IN VARIOUS LIVER DISEASES].
    MINERVA V; GRIMALDI N; GILLARDI U; BONOMO L
    Policlinico Med; 1963 Oct; 70():292-306. PubMed ID: 14098540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation between sulfobromophthalein Au-198 clearance and scintigraphic aspects in hepatopathies].
    Maduli S; Castagnetti GL
    G Clin Med; 1970 Mar; 51(3):180-256. PubMed ID: 5477744
    [No Abstract]   [Full Text] [Related]  

  • 7. [ADVANTAGES AND DISADVANTAGES OF BROMSULPHALEIN (BSP) RETENTION TESTS].
    TICHY J
    Cesk Gastroenterol Vyz; 1963 Apr; 17():168-74. PubMed ID: 14054844
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic value of the combined BSP-indocyanine green test with continuous recording].
    Lemonnier F; Chevrel B; Caroli J
    Pathol Biol (Paris); 1969; 17(15):687-95. PubMed ID: 4907900
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of the ujoviridine test as compared with the bromsulfan test in acute and chronic hepatopathies].
    Wildt F; Wagner K; Wildt S
    Z Arztl Fortbild (Jena); 1977 Sep; 71(18):841-3. PubMed ID: 595629
    [No Abstract]   [Full Text] [Related]  

  • 10. [BROMTHALEIN TEST IN CHRONIC HEPATITIS].
    LISICHKINA VS
    Klin Med (Mosk); 1963 Aug; 41():128-34. PubMed ID: 14090805
    [No Abstract]   [Full Text] [Related]  

  • 11. [BSP--its values in various liver diseases and the function test by 121-I-BSP].
    Ito K; Nakagawa J; Minakuchi C; Tamai Y; Nakano H
    Nihon Rinsho; 1971 Jan; 29():Suppl:341-50. PubMed ID: 4928278
    [No Abstract]   [Full Text] [Related]  

  • 12. [Functional exploration of the liver with sulfobromophthalein (BSF)].
    Pippi L; Toti M; Alegente G; Frosini G; Lombardini L
    Quad Sclavo Diagn; 1972 Sep; 8(3):829-54. PubMed ID: 4671771
    [No Abstract]   [Full Text] [Related]  

  • 13. [DIAGNOSTIC VALUE OF THE COUPLED BROMSULPHALEIN-INDOCYANIN GREEN TEST IN HEPATO-BILIARY PATHOLOGY].
    LEMONNIER F; JULIEN C; CHEVREL B; CAROLI J
    Pathol Biol; 1963 Dec; 11():1362-72. PubMed ID: 14115977
    [No Abstract]   [Full Text] [Related]  

  • 14. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of ICG and BSP elimination through the liver at different dosages].
    Jaross W; Schentke KU; Richter B; Tschöpel L; Renger F
    Z Gesamte Inn Med; 1970 Sep; 25(18):834-40. PubMed ID: 5522140
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfobromophthalein (BSP) metabolism in viral hepatitis, liver cirrhosis and hereditarv spherocvtosis.
    HOENIG V; JIRSA M; HOENIGOVA J
    Acta Hepatosplenol; 1961 Aug; 8():217-26. PubMed ID: 13714916
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the significance of BSF clearance in chronic post-hepatitis liver diseases].
    Camilloni R; Ghinelli F; Pizzaferri A; Pizzigoni G; Fiaccadori F
    G Clin Med; 1972 Jul; 53(7):327-33. PubMed ID: 4666410
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical value of the fractional clearance of BSP in hepatic functional exploration and in diagnosis of chronic liver diseases].
    Oancea R; Suman S; Filip V; Macarie O; Ciocan A
    Med Interna (Bucur); 1966 Oct; 18(10):1233-40. PubMed ID: 5978450
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bromsulphalein test (BSP): test results in various liver diseases].
    Ito K; Nakagawa J; Minakuchi C; Tamai Y; Sano M
    Nihon Rinsho; 1969 Mar; ():Suppl:844-52. PubMed ID: 4948299
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL, BIOCHEMICAL AND ANATOMOPATHOLOGICAL STUDY OF CHRONIC HEPATITIS AND POSTHEPATITIS CIRRHOSIS].
    DEGROOTE J
    Verh K Vlaam Acad Geneeskd Belg; 1964; 26():85-171. PubMed ID: 14158180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.